Selected research
Industry Research
Biologics Process Development Service Industry Research Report 2026
Market perspective
The global Biologics Process Development Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biologics Process Development Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biologics Process Development Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biologics Process Development Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biologics Process Development Service include AGC Biologics, Bora Biologics, Canton Biologics, Catalent Biologics, Evotec, HIPRA, Kemwell Pharma, Lonza and Mabion, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biologics Process Development Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biologics Process Development Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biologics Process Development Service Market by Company
AGC Biologics
Bora Biologics
Canton Biologics
Catalent Biologics
Evotec
HIPRA
Kemwell Pharma
Lonza
Mabion
NorthX Biologics
Pace Analytical
Rodon Biologics
Samsung Biologics
Sartorius
Thermo Fisher Scientific
WuXi Biologics
Biologics Process Development Service Segment by Type
R&D Scale (1-3L)
Pilot and Scale-Up (50-500L)
Clinical and Commercial Production Scale (1000L and Above)
Biologics Process Development Service Segment by Application
Contract Development and Manufacturing Organization (CDMO)
Professional Technical Service Provider
Large Pharmaceutical Company
Research Institute
Biologics Process Development Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Process Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biologics Process Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Process Development Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biologics Process Development Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- R&D Scale (1-3L)
- Pilot and Scale-Up (50-500L)
- Clinical and Commercial Production Scale (1000L and Above)
Applications
- Contract Development and Manufacturing Organization (CDMO)
- Professional Technical Service Provider
- Large Pharmaceutical Company
- Research Institute
Companies covered
- AGC Biologics
- Bora Biologics
- Canton Biologics
- Catalent Biologics
- Evotec
- HIPRA
- Kemwell Pharma
- Lonza
- Mabion
- NorthX Biologics
- Pace Analytical
- Rodon Biologics
- Samsung Biologics
- Sartorius
- Thermo Fisher Scientific
- WuXi Biologics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biologics Process Development Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 R&D Scale (1-3L)
- 2.2.3 Pilot and Scale-Up (50-500L)
- 2.2.4 Clinical and Commercial Production Scale (1000L and Above)
- 2.3 Biologics Process Development Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Contract Development and Manufacturing Organization (CDMO)
- 2.3.3 Professional Technical Service Provider
- 2.3.4 Large Pharmaceutical Company
- 2.3.5 Research Institute
- 2.4 Assumptions and Limitations
3 Biologics Process Development Service Breakdown Data by Type
- 3.1 Global Biologics Process Development Service Historic Market Size by Type (2021-2026)
- 3.2 Global Biologics Process Development Service Forecasted Market Size by Type (2027-2032)
4 Biologics Process Development Service Breakdown Data by Application
- 4.1 Global Biologics Process Development Service Historic Market Size by Application (2021-2026)
- 4.2 Global Biologics Process Development Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biologics Process Development Service Market Perspective (2021-2032)
- 5.2 Global Biologics Process Development Service Growth Trends by Region
- 5.2.1 Global Biologics Process Development Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biologics Process Development Service Historic Market Size by Region (2021-2026)
- 5.2.3 Biologics Process Development Service Forecasted Market Size by Region (2027-2032)
- 5.3 Biologics Process Development Service Market Dynamics
- 5.3.1 Biologics Process Development Service Industry Trends
- 5.3.2 Biologics Process Development Service Market Drivers
- 5.3.3 Biologics Process Development Service Market Challenges
- 5.3.4 Biologics Process Development Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biologics Process Development Service Players by Revenue
- 6.1.1 Global Top Biologics Process Development Service Players by Revenue (2021-2026)
- 6.1.2 Global Biologics Process Development Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Biologics Process Development Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biologics Process Development Service Head Office and Area Served
- 6.4 Global Biologics Process Development Service Players, Product Type & Application
- 6.5 Global Biologics Process Development Service Manufacturers Established Date
- 6.6 Global Biologics Process Development Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biologics Process Development Service Market Size (2021-2032)
- 7.2 North America Biologics Process Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biologics Process Development Service Market Size by Country (2021-2026)
- 7.4 North America Biologics Process Development Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biologics Process Development Service Market Size (2021-2032)
- 8.2 Europe Biologics Process Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biologics Process Development Service Market Size by Country (2021-2026)
- 8.4 Europe Biologics Process Development Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biologics Process Development Service Market Size (2021-2032)
- 9.2 Asia-Pacific Biologics Process Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biologics Process Development Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biologics Process Development Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biologics Process Development Service Market Size (2021-2032)
- 10.2 South America Biologics Process Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biologics Process Development Service Market Size by Country (2021-2026)
- 10.4 South America Biologics Process Development Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biologics Process Development Service Market Size (2021-2032)
- 11.2 Middle East & Africa Biologics Process Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biologics Process Development Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biologics Process Development Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AGC Biologics
- 12.1.1 AGC Biologics Company Information
- 12.1.2 AGC Biologics Business Overview
- 12.1.3 AGC Biologics Revenue in Biologics Process Development Service Business (2021-2026)
- 12.1.4 AGC Biologics Biologics Process Development Service Product Portfolio
- 12.1.5 AGC Biologics Recent Developments
- 12.2 Bora Biologics
- 12.2.1 Bora Biologics Company Information
- 12.2.2 Bora Biologics Business Overview
- 12.2.3 Bora Biologics Revenue in Biologics Process Development Service Business (2021-2026)
- 12.2.4 Bora Biologics Biologics Process Development Service Product Portfolio
- 12.2.5 Bora Biologics Recent Developments
- 12.3 Canton Biologics
- 12.3.1 Canton Biologics Company Information
- 12.3.2 Canton Biologics Business Overview
- 12.3.3 Canton Biologics Revenue in Biologics Process Development Service Business (2021-2026)
- 12.3.4 Canton Biologics Biologics Process Development Service Product Portfolio
- 12.3.5 Canton Biologics Recent Developments
- 12.4 Catalent Biologics
- 12.4.1 Catalent Biologics Company Information
- 12.4.2 Catalent Biologics Business Overview
- 12.4.3 Catalent Biologics Revenue in Biologics Process Development Service Business (2021-2026)
- 12.4.4 Catalent Biologics Biologics Process Development Service Product Portfolio
- 12.4.5 Catalent Biologics Recent Developments
- 12.5 Evotec
- 12.5.1 Evotec Company Information
- 12.5.2 Evotec Business Overview
- 12.5.3 Evotec Revenue in Biologics Process Development Service Business (2021-2026)
- 12.5.4 Evotec Biologics Process Development Service Product Portfolio
- 12.5.5 Evotec Recent Developments
- 12.6 HIPRA
- 12.6.1 HIPRA Company Information
- 12.6.2 HIPRA Business Overview
- 12.6.3 HIPRA Revenue in Biologics Process Development Service Business (2021-2026)
- 12.6.4 HIPRA Biologics Process Development Service Product Portfolio
- 12.6.5 HIPRA Recent Developments
- 12.7 Kemwell Pharma
- 12.7.1 Kemwell Pharma Company Information
- 12.7.2 Kemwell Pharma Business Overview
- 12.7.3 Kemwell Pharma Revenue in Biologics Process Development Service Business (2021-2026)
- 12.7.4 Kemwell Pharma Biologics Process Development Service Product Portfolio
- 12.7.5 Kemwell Pharma Recent Developments
- 12.8 Lonza
- 12.8.1 Lonza Company Information
- 12.8.2 Lonza Business Overview
- 12.8.3 Lonza Revenue in Biologics Process Development Service Business (2021-2026)
- 12.8.4 Lonza Biologics Process Development Service Product Portfolio
- 12.8.5 Lonza Recent Developments
- 12.9 Mabion
- 12.9.1 Mabion Company Information
- 12.9.2 Mabion Business Overview
- 12.9.3 Mabion Revenue in Biologics Process Development Service Business (2021-2026)
- 12.9.4 Mabion Biologics Process Development Service Product Portfolio
- 12.9.5 Mabion Recent Developments
- 12.10 NorthX Biologics
- 12.10.1 NorthX Biologics Company Information
- 12.10.2 NorthX Biologics Business Overview
- 12.10.3 NorthX Biologics Revenue in Biologics Process Development Service Business (2021-2026)
- 12.10.4 NorthX Biologics Biologics Process Development Service Product Portfolio
- 12.10.5 NorthX Biologics Recent Developments
- 12.11 Pace Analytical
- 12.11.1 Pace Analytical Company Information
- 12.11.2 Pace Analytical Business Overview
- 12.11.3 Pace Analytical Revenue in Biologics Process Development Service Business (2021-2026)
- 12.11.4 Pace Analytical Biologics Process Development Service Product Portfolio
- 12.11.5 Pace Analytical Recent Developments
- 12.12 Rodon Biologics
- 12.12.1 Rodon Biologics Company Information
- 12.12.2 Rodon Biologics Business Overview
- 12.12.3 Rodon Biologics Revenue in Biologics Process Development Service Business (2021-2026)
- 12.12.4 Rodon Biologics Biologics Process Development Service Product Portfolio
- 12.12.5 Rodon Biologics Recent Developments
- 12.13 Samsung Biologics
- 12.13.1 Samsung Biologics Company Information
- 12.13.2 Samsung Biologics Business Overview
- 12.13.3 Samsung Biologics Revenue in Biologics Process Development Service Business (2021-2026)
- 12.13.4 Samsung Biologics Biologics Process Development Service Product Portfolio
- 12.13.5 Samsung Biologics Recent Developments
- 12.14 Sartorius
- 12.14.1 Sartorius Company Information
- 12.14.2 Sartorius Business Overview
- 12.14.3 Sartorius Revenue in Biologics Process Development Service Business (2021-2026)
- 12.14.4 Sartorius Biologics Process Development Service Product Portfolio
- 12.14.5 Sartorius Recent Developments
- 12.15 Thermo Fisher Scientific
- 12.15.1 Thermo Fisher Scientific Company Information
- 12.15.2 Thermo Fisher Scientific Business Overview
- 12.15.3 Thermo Fisher Scientific Revenue in Biologics Process Development Service Business (2021-2026)
- 12.15.4 Thermo Fisher Scientific Biologics Process Development Service Product Portfolio
- 12.15.5 Thermo Fisher Scientific Recent Developments
- 12.16 WuXi Biologics
- 12.16.1 WuXi Biologics Company Information
- 12.16.2 WuXi Biologics Business Overview
- 12.16.3 WuXi Biologics Revenue in Biologics Process Development Service Business (2021-2026)
- 12.16.4 WuXi Biologics Biologics Process Development Service Product Portfolio
- 12.16.5 WuXi Biologics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst